Replies to post #3325 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

New insider purchase: CEO Geoff Cox bought 14,200 shares today on the open market:

http://www.sec.gov/Archives/edgar/data/904973/000090866207000291/xslF345X02/edgar.xml

Dr. Cox bought 38,000 shares on the open market in Nov 2006 and Mar 2007 (#msg-18919535), which brings his cumulative open-market purchases to approximately 52K shares during the past nine months.

After today’s purchase, Dr. Cox owns 265,000 shares of GTCB stock. (This excludes Cox’s more than 700,000 vested options.)